基于核酸的治疗有效管理类风湿性关节炎
Yashpreet Singh1, Aniket Singh1, Priscar Geoffrey1
1School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Phagwara GT Road, Punjab, 144411, India.
Current pharmaceutical design
|July 16, 2025
概括
基于核酸的疗法为传统的风湿性关节炎 (RA) 治疗提供了一个有希望的替代方案,因为它针对疾病.
科学领域:
- 免疫学和分子医学
- 类风湿病学 类风湿病学
- 生物技术是生物技术.
背景情况:
- 风湿性关节炎 (RA) 是一种慢性自身免疫性关节疾病,导致炎症,疼痛和不运动.
- 目前的药物治疗提供症状缓解,但缺乏长期疗效.
- 迫切需要针对RA根源的替代疗法.
研究的目的:
- 审查基于核酸的类风湿性关节炎 (RA) 治疗策略.
- 评估这些新型治疗方法的临床疗效,安全性和益处.
- 讨论核酸治疗的药理动力学挑战和输送解决方案.
主要方法:
- 探索各种基于核酸的技术,包括反意义寡核酸,siRNA,CRISPR-Cas9,RNA疫苗,miRNA疗法和表观遗传修饰.
- 对这些RA治疗方法的临床前和临床研究进行了广泛的评估.
- 对药物动力学挑战和基于纳米粒子的输送系统的分析.
主要成果:
- 基于核酸的疗法显示出向RA病变机制的潜力.
- 临床和临床前数据表明疗效和治疗效益.
- 纳米粒子输送系统在克服降解和吸收问题方面显示出前景.
结论:
- 基于核酸的疗法代表了RA治疗的重大进步.
- 这些方法提供了更有效,更少的毒性和以患者为中心的管理选择.
- 这一领域有望改善RA患者的生活质量.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237
Rheumatic Heart Disease III: Medical Management
35
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
35
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
272
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
272
Inflammatory Bowel Disease IV: Pharmacological Management
198
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
198
Rheumatic Heart Disease IV: Nursing Management
40
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
40
Genome-wide Association Studies-GWAS
14.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.3K


